painkillers

FDA clears first opioid withdrawal deviceFDA granted a new indication to a device that can help reduce the symptoms of withdrawal from the prescription pain drugs.
DEA wants to slash opioid productionThe Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
More resources needed for medication-assisted treatmentInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.
Are states going too far with painkiller script limits?Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
HHS tackles opioid epidemicHHS is taking formal steps to address opioid addiction, a widely recognized national public health crisis. Find out the policy changes.
New payer trends for opioids coincide with epidemicA new study examines payer payment shifts for opioids.
One thing we can do about the opioid epidemicIt's a modest proposal with potential for significant consequences. And all it will cost is a little more time.
Obama rejects governors' proposal to limit painkiller RxsPresident Obama this week rejected a proposal from the nation’s governors that sought to fight the heroin epidemic by limiting the number of painkillers doctors could prescribe.
Balancing opioid benefits, dangersOpioids are powerful clinical tools that effectively treat pain and have a place in therapy, but it can be difficult to manage the dangers. Here's a look at some of the abuse-deterrent drugs on the horizon.
FDA panel greenlights Probuphine for opioid addictionFDA advisers recommended approval of the first long-acting, subdermal buprenorphine implant (Probuphine, Titan Pharmaceuticals, Inc. and Braeburn Pharmaceuticals) for the maintenance treatment of opioid addiction.